GleamWall
中文EN

CDNA CareDx, Inc.

Services-Medical Laboratories · Nasdaq · SEC CIK 1217234 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY38.9%
TTM net income YoY111.7%
TTM EPS YoY85.2%
Revenue 3-yr CAGR18.7%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin23.4%
Net margin25.9%
FCF margin—
EBITDA margin27.0%

Returns

ROE33.0%
ROA24.0%
ROIC (approx.)53.4%
Asset turnover0.93x

Leverage & solvency

Liabilities / assets27.1%
Debt / equity0.00x
Current ratio2.31x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.54x
Accruals ratio11.1%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$139.36M$131.95M$117.70M$108.39M$100.06M$86.68M$84.69M$86.58M
R&D expense$21.32M$22.38M$21.42M$19.31M$16.77M$16.83M$18.52M$16.62M
SG&A expense$37.99M$40.91M$30.48M$28.68M$28.43M$27.68M$22.77M$32.35M
Operating income$8.11M$113.22M$1.20M-$6.04M-$246,000-$11.12M-$13.37M$74.69M
Pretax income$10.69M$114.52M$2.78M-$3.76M$1.66M-$8.69M-$10.29M$87.87M
Income tax-$8.60M$3.88M-$32,012$345,000-$15,000-$117,000$58,000$171,000
Net income$19.29M$110.64M$2.81M-$4.11M$1.68M-$8.57M-$10.35M$78.01M
EBITDA$15.32M$116.03M$5.10M-$2.16M$3.57M-$7.40M-$9.77M$78.05M
EPS (basic)0.372.150.05—0.03-0.16-0.19—
EPS (diluted)0.352.070.05—0.03-0.16-0.19—
Weighted avg. shares (diluted)54.98M53.42M53.13M—53.74M54.30M55.26M—
Balance sheet
Cash & equivalents$250.48M$373.64M$77.92M$65.43M$91.44M$68.21M$88.75M$115.27M
Short-term investments$0$0$109.25M$111.78M$102.78M$118.04M$142.17M$145.96M
Receivables$47.73M$34.38M$44.59M$42.63M$47.84M$67.36M$71.48M$64.61M
Inventory$9.14M$6.98M$26.40M$26.70M$28.33M$27.91M$22.93M$19.50M
Current assets$321.30M$429.22M$269.39M$257.13M$300.28M$307.30M$350.24M$351.83M
PP&E, net$27.01M$26.84M$33.16M$32.97M$30.84M$31.93M$32.73M$33.55M
Goodwill$121.71M$35.97M$40.34M$40.34M$40.34M$40.34M$40.34M$40.34M
Intangibles$139.78M$18.56M$32.10M$31.96M$33.45M$36.04M$37.25M$38.18M
Total assets$641.46M$532.99M$411.06M$413.23M$432.31M$444.26M$489.64M$491.05M
Current liabilities$138.97M$93.70M$79.15M$89.85M$99.04M$93.18M$85.28M$89.37M
Total liabilities$174.00M$107.39M$97.53M$110.13M$121.17M$116.89M$110.29M$112.62M
Shareholders' equity$467.46M$425.60M$313.54M$303.10M$311.14M$327.37M$379.35M$378.43M
Shares outstanding52.46M51.48M51.27M50.92M51.41M53.22M55.46M54.77M
Cash flow statement
Operating cash flow$12.72M$30.60M$4.33M$21.36M$37.36M$9.89M-$26.58M$21.89M
Capital expenditure$1.61M$1.86M$3.82M—$1.30M$1.01M$1.63M—
Free cash flow$11.10M$28.75M$514,000—$36.05M$8.89M-$28.21M—
Investing cash flow-$147.88M$280.59M$11.06M-$34.91M$12.35M$23.40M$1.32M-$2.11M
Financing cash flow$12.90M-$15.50M-$2.91M-$12.46M-$26.48M-$53.81M-$643,000-$903,000
Depreciation & amortization$7.20M$2.81M$3.90M$3.88M$3.81M$3.72M$3.60M$3.36M
Stock-based compensation$9.65M$10.65M$9.80M$8.09M$8.42M$9.42M$8.93M$26.20M
Share buybacks$0——$12.21M$25.56M$50.00M$0$0

Free plan shows the latest 8 periods; Pro shows all 55 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.